Navigating the Regulatory Landscape in Clinical Trials in 2024
About this webinar
Staying current with regulatory changes is important when it comes to staying out of trouble with regulatory agencies, maintaining your reputation, and successfully conducting clinical trials. Join Marc Wartenberger, Director Corporate QA & Compliance at CRIO, for a review of new regulations, guidance, and decisions from 2023 that will impact clinical research. Highlights include:
- New Part 11 guidance
- FDA DCT guidance
- FDA Patient Diversity guidance
- EU-US Data Privacy Framework
The featured speaker will also provide insights into anticipated changes for 2024. Webinar participants will:
- Review industry regulations and guidance on Decentralized Clinical Trials (DCT), Electronic Records & Signatures (Part 11), Patient Diversity, and EU-US Data Privacy Framework.
- Formulate a plan to avoid regulatory repercussions by preparing for upcoming trial directives and changes that impact clinical research.
- Identify strategies to prepare for regulatory changes by adapting your operations.
The webinar will include practical advice for how to stay compliant with real world examples from Marc’s experience. Join this webinar to explore pivotal regulatory updates affecting clinical research and proactive strategies.
Who should attend
- Clinical operations personnel
- Data management and data science personnel
- Clinical Research Coordinators and PIs
- Regulatory and QA professionals
What you will learn
- Review industry regulations and guidance on Decentralized Clinical Trials (DCT), Electronic Records & Signatures (Part 11), Patient Diversity, and EU-US Data Privacy Framework.
- Formulate a plan to avoid regulatory repercussions by preparing for upcoming trial directives and changes that impact clinical research.
- Identify strategies to prepare for regulatory changes by adapting your operations.
Featured Speakers
Marc Wartenberger
As the Director of Security, Corporate QA and Compliance, Marc Wartenberger is leading the corporate security, quality and compliance initiatives at CRIO. Additionally, he is serving as CRIO’s Data Protection Officer. Prior to CRIO, Marc was leading the quality assurance efforts at snapIoT, now part of Labcorp Drug Development. Before snapIoT, Marc was a key member of the corporate compliance and QA group at Clinical Ink from 2012-2021 and served as its Data Protection Officer from 2018 to 2021.
Partner for this event
CRIO
CRIO is an eClinical solution provider delivering innovative data capture technology for sites, sponsors and CROs. As the industry’s leading eSource provider, CRIO’s unique architecture enables a single point of data capture that embeds quality and transparency at the point of entry, and creates significant downstream efficiencies. Finally. One system. One source.
Related webinars
More from CRIO.
The Rise of the Site: How to Empower Efficient Clinical Study Execution
Using Technology to Reduce Monitoring Costs and Increase Quality
Clinical Trial Sites: The Rise of the Mega Network
Are Regulators Driving or Impeding Innovation in Clinical Trials?
Clinical Trial Site Burden & Clinical Research Associate Burnout — How Studies Suffer
How Site-Based eSource Benefits Sponsors by Boosting Site Success
Advancing Data Management and Monitoring – Change the Game With Integrated eSource/EMR/EDC